David Miles Meredith, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Neoplasms | 7 | 2023 | 928 | 2.230 |
Why?
|
Glioma | 13 | 2025 | 3503 | 1.540 |
Why?
|
Brain Neoplasms | 15 | 2025 | 9118 | 0.940 |
Why?
|
Neural Tube | 4 | 2016 | 48 | 0.660 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11095 | 0.640 |
Why?
|
Retinal Neoplasms | 1 | 2021 | 151 | 0.640 |
Why?
|
Pathology, Surgical | 1 | 2020 | 148 | 0.630 |
Why?
|
Retinoblastoma | 1 | 2021 | 321 | 0.610 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 253 | 0.600 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 156 | 0.600 |
Why?
|
Chondroma | 1 | 2018 | 53 | 0.590 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.550 |
Why?
|
Facial Bones | 1 | 2018 | 209 | 0.540 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 498 | 0.540 |
Why?
|
Glioblastoma | 4 | 2025 | 3464 | 0.530 |
Why?
|
Fibroma | 1 | 2018 | 197 | 0.530 |
Why?
|
Ependymoma | 1 | 2019 | 328 | 0.520 |
Why?
|
Homeodomain Proteins | 2 | 2021 | 2430 | 0.440 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1164 | 0.400 |
Why?
|
Trans-Activators | 1 | 2021 | 2857 | 0.380 |
Why?
|
Lymphoma | 1 | 2020 | 1898 | 0.360 |
Why?
|
NF-kappa B | 1 | 2019 | 2494 | 0.360 |
Why?
|
Transcription Factors | 8 | 2022 | 12171 | 0.330 |
Why?
|
Gene Expression Regulation, Developmental | 6 | 2016 | 3610 | 0.320 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2565 | 0.310 |
Why?
|
Pancreas | 2 | 2013 | 1699 | 0.310 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2014 | 1143 | 0.250 |
Why?
|
Proteins | 1 | 2019 | 6009 | 0.230 |
Why?
|
Neurogenesis | 2 | 2014 | 864 | 0.230 |
Why?
|
Central Nervous System | 2 | 2022 | 1346 | 0.230 |
Why?
|
Chromatin | 3 | 2022 | 2981 | 0.220 |
Why?
|
Histocytochemistry | 1 | 2024 | 699 | 0.210 |
Why?
|
Meningioma | 2 | 2022 | 1220 | 0.210 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1253 | 0.210 |
Why?
|
Lithotripsy | 1 | 2023 | 137 | 0.200 |
Why?
|
Ribonuclease III | 2 | 2022 | 271 | 0.200 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2023 | 131 | 0.200 |
Why?
|
Spinal Cord | 4 | 2016 | 1812 | 0.190 |
Why?
|
DEAD-box RNA Helicases | 2 | 2022 | 385 | 0.180 |
Why?
|
Child | 13 | 2025 | 80917 | 0.180 |
Why?
|
Transducin | 1 | 2020 | 42 | 0.180 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2013 | 133 | 0.180 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.180 |
Why?
|
Pathology, Clinical | 1 | 2024 | 375 | 0.180 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 168 | 0.180 |
Why?
|
World Health Organization | 2 | 2023 | 1328 | 0.180 |
Why?
|
Sarcoma | 2 | 2022 | 1806 | 0.170 |
Why?
|
Prognosis | 9 | 2025 | 30009 | 0.170 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.170 |
Why?
|
Nitriles | 1 | 2024 | 980 | 0.160 |
Why?
|
Oncogene Fusion | 1 | 2019 | 84 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
Transcription, Genetic | 3 | 2009 | 7609 | 0.160 |
Why?
|
Facial Paralysis | 1 | 2023 | 346 | 0.160 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4528 | 0.160 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 125 | 0.150 |
Why?
|
Homeostasis | 1 | 2009 | 3348 | 0.150 |
Why?
|
Pattern Recognition, Automated | 1 | 2024 | 993 | 0.150 |
Why?
|
Humans | 41 | 2025 | 768171 | 0.150 |
Why?
|
Hemangioma | 1 | 2023 | 727 | 0.150 |
Why?
|
Mitotic Index | 1 | 2018 | 162 | 0.150 |
Why?
|
Aneuploidy | 1 | 2021 | 573 | 0.150 |
Why?
|
Lymphoma, T-Cell | 1 | 2020 | 308 | 0.140 |
Why?
|
Granuloma, Plasma Cell | 1 | 2018 | 80 | 0.140 |
Why?
|
Chick Embryo | 4 | 2016 | 975 | 0.140 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2020 | 1613 | 0.140 |
Why?
|
California | 1 | 2021 | 1438 | 0.140 |
Why?
|
Demyelinating Diseases | 1 | 2019 | 358 | 0.140 |
Why?
|
Young Adult | 10 | 2025 | 60066 | 0.130 |
Why?
|
Astrocytoma | 1 | 2020 | 774 | 0.130 |
Why?
|
Adolescent | 12 | 2025 | 89169 | 0.130 |
Why?
|
Mutation | 9 | 2025 | 30237 | 0.130 |
Why?
|
Mouth Diseases | 1 | 2018 | 239 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 2 | 2016 | 286 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2022 | 1628 | 0.120 |
Why?
|
Adult | 14 | 2025 | 223646 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2433 | 0.110 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 558 | 0.110 |
Why?
|
Genetic Markers | 1 | 2020 | 2603 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2023 | 1401 | 0.110 |
Why?
|
Mice, Transgenic | 5 | 2016 | 9561 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2013 | 64 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 2020 | 945 | 0.110 |
Why?
|
Child, Preschool | 6 | 2023 | 42669 | 0.110 |
Why?
|
Base Sequence | 6 | 2016 | 12422 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2025 | 9419 | 0.110 |
Why?
|
Consensus Sequence | 1 | 2013 | 363 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2016 | 792 | 0.100 |
Why?
|
Pituitary Neoplasms | 1 | 2021 | 1322 | 0.100 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 520 | 0.100 |
Why?
|
Tumor Burden | 1 | 2018 | 1906 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1901 | 0.100 |
Why?
|
Parietal Lobe | 1 | 2016 | 866 | 0.090 |
Why?
|
Male | 19 | 2025 | 364731 | 0.090 |
Why?
|
Neural Inhibition | 1 | 2014 | 588 | 0.090 |
Why?
|
Histones | 1 | 2020 | 2601 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2015 | 1394 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1596 | 0.080 |
Why?
|
Infant | 5 | 2023 | 36535 | 0.080 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 806 | 0.080 |
Why?
|
Cerebellum | 1 | 2016 | 1522 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1092 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.080 |
Why?
|
Seizures | 2 | 2024 | 2998 | 0.080 |
Why?
|
Female | 17 | 2025 | 397187 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9374 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2982 | 0.070 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 431 | 0.070 |
Why?
|
Software | 1 | 2021 | 4480 | 0.070 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2016 | 1077 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2025 | 81760 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2009 | 482 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5536 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3591 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2025 | 951 | 0.070 |
Why?
|
Genetic Loci | 1 | 2015 | 2629 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2009 | 4413 | 0.070 |
Why?
|
Protein Binding | 3 | 2014 | 9343 | 0.070 |
Why?
|
Middle Aged | 10 | 2025 | 223487 | 0.060 |
Why?
|
Biopsy | 1 | 2018 | 6792 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1437 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1752 | 0.060 |
Why?
|
Neurons | 3 | 2014 | 9514 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3670 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15453 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2025 | 65379 | 0.060 |
Why?
|
Mice | 9 | 2020 | 82049 | 0.060 |
Why?
|
Geniculate Ganglion | 1 | 2023 | 9 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3604 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2024 | 334 | 0.050 |
Why?
|
Aged | 8 | 2025 | 171502 | 0.050 |
Why?
|
Zinc Fingers | 2 | 2016 | 577 | 0.050 |
Why?
|
E-Box Elements | 2 | 2014 | 21 | 0.050 |
Why?
|
Binding Sites | 4 | 2014 | 6019 | 0.050 |
Why?
|
Cell Line | 2 | 2013 | 15602 | 0.050 |
Why?
|
Animals | 10 | 2022 | 169285 | 0.050 |
Why?
|
Facial Nerve | 1 | 2023 | 277 | 0.040 |
Why?
|
Genome | 2 | 2021 | 1754 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 371 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7213 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2395 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2023 | 1497 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2892 | 0.040 |
Why?
|
Homozygote | 1 | 2023 | 1779 | 0.040 |
Why?
|
Palate, Hard | 1 | 2018 | 59 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1078 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 785 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 633 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17623 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1135 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59626 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 614 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2022 | 2521 | 0.030 |
Why?
|
Polymers | 1 | 2023 | 1630 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1228 | 0.030 |
Why?
|
Lysine | 1 | 2020 | 1000 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2013 | 1676 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22371 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2359 | 0.030 |
Why?
|
Electroporation | 1 | 2016 | 239 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 917 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2024 | 1923 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3346 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 22380 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2059 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1836 | 0.030 |
Why?
|
PAX2 Transcription Factor | 1 | 2013 | 86 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3623 | 0.030 |
Why?
|
Glutamates | 1 | 2014 | 385 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 2015 | 403 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2025 | 8542 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4120 | 0.030 |
Why?
|
Chickens | 1 | 2014 | 845 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 2 | 2009 | 1367 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2009 | 7876 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3612 | 0.020 |
Why?
|
Cell Differentiation | 3 | 2016 | 11677 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8741 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6525 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3721 | 0.020 |
Why?
|
Survival Rate | 1 | 2025 | 12840 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 858 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1750 | 0.020 |
Why?
|
Stem Cells | 2 | 2016 | 3538 | 0.020 |
Why?
|
Body Patterning | 1 | 2014 | 634 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1904 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14729 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4786 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10099 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2008 | 31 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2828 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2474 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3948 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 2028 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 5797 | 0.020 |
Why?
|
Dimerization | 1 | 2009 | 887 | 0.020 |
Why?
|
Vertebrates | 1 | 2008 | 227 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4446 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2018 | 3474 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8052 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20225 | 0.020 |
Why?
|
Pyridines | 1 | 2018 | 2894 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5028 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8509 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5926 | 0.020 |
Why?
|
Retina | 1 | 2016 | 2662 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 1162 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13668 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3428 | 0.010 |
Why?
|
Epithelium | 1 | 2008 | 1607 | 0.010 |
Why?
|
Risk Assessment | 1 | 2025 | 24318 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2025 | 39354 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1110 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7140 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16726 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5704 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 13013 | 0.010 |
Why?
|
Electroencephalography | 1 | 2016 | 6314 | 0.010 |
Why?
|
Prospective Studies | 1 | 2025 | 54924 | 0.010 |
Why?
|
Models, Genetic | 1 | 2008 | 3447 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14488 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 19025 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20762 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23782 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 23648 | 0.000 |
Why?
|